Introduction

First neural stem cell transplant into patient with sensory function below the level of injury

First neural stem cell transplant into patient with sensory function below the level of injury

As part of their phase I/II clinical trial in chronic spinal cord injury, StemCells, Inc. has for the first time transplanted HuCNS-SC® neural stem cells into a patient with an incomplete spinal cord injury. This is the first patient in the second cohort of the trial, which will be comprised of four patients who retain some sensory function below the level of trauma.

“Given the encouraging interim data from the most severely injured patient cohort that we reported earlier this month, testing patients with less severe injury should afford us an even better opportunity to continue to test safety and to detect and assess clinical changes.” said Dr Stephen Huhn, Head of the CNS Program at StemCells, Inc. “Unlike the patients in the first cohort, patients with incomplete injuries have retained a degree of spinal cord function that might be even further augmented by transplantation with neural stem cells.” 


Read more…